Publications

Publications

305 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Period from
to

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a publication you are looking for, such as press releases or speeches

Sort by: Date / Relevance

Hydroquinine (Inhibin®) for patients with nocturnal muscle cramps

Zorginstituut Nederland has assessed whether hydroquinine (Inhibin®) should be included in the medication reimbursement system ...

Report | 04-03-2020

Voretigene neparvovec (Luxturna®) for the treatment of vision loss due to inherited retinal dystrophy with bi-allelic RPE65 mutations

Zorginstituut Nederland has completed its assessment whether voretigene neparvovec (Luxturna®) for the treatment of vision loss ...

Report | 17-02-2020

Emicizumab (Hemlibra®) for the prophylactic treatment of bleeding in patients with severe haemophilia A without inhibitors

Zorginstituut Nederland has completed its assessment whether emicizumab (Hemlibra®) for the prophylactic treatment of bleeding in ...

Report | 17-02-2020

GVS assessment of racecadotril (Hidrasec®) for the treatment of acute diarrhoea in infants (over 3 months of age) and children

The Zorginstituut has completed its assessment whether racecadotril (Hidrasec®) is interchangeable with another product that is ...

Report | 17-12-2019

GVS assessment of a 4 component meningococcal B vaccine (Bexsero®)

Zorginstituut Nederland has completed its assessment whether the product 4 component meningococcal B vaccine (4CMenB) (Bexsero®) ...

Report | 16-12-2019

Metreleptin (Myalepta®) for treatment of lipodystrophy

Zorginstituut Nederland has completed its assessment whether metreleptin (Myalepta®) for treatment of lipodystrophy can be ...

Report | 21-10-2019

GVS assessment of extension of further conditions for GLP-1ra

The minister for Medical Care asked Zorginstituut Nederland to extend the further conditions for the glucagon-like peptide 1 ...

Report | 26-09-2019

Ciclosporin (Ikervis®) for the treatment of severe keratitis in adult patients with the dry eye syndrome

Zorginstituut Nederland has completed its assessment whether ciclosporin (Ikervis®) for the treatment of severe keratitis in ...

Report | 18-09-2019

Dabrafenib/trametinib (Tafinlar®/Mekinist®) for the adjuvant treatment of adult patients with stage III melanoma

Zorginstituut Nederland has completed its assessment of dabrafenib (Tafinlar®) in combination with trametinib (Mekinist®) for the ...

Report | 28-08-2019

GVS assessment of fampridine (Fampyra®) for use in a subgroup of MS patients

Zorginstituut Nederland has completed its assessment whether fampridine (Fampyra®) can be included in the Medication ...

Report | 06-08-2019